This study relied solely on computational data to establish HSD3B7 as a prognostic biomarker, but the lack of experimental validation limited understanding of its functional role and underlying mechanisms in ccRCC progression. Here, HSD3B7 is linked to nonpapillary renal cell carcinoma.